All In Biotech

Drug Trial Radar · NCT02541955

Use of Acthar in Rheumatoid Arthritis (RA) Related Flares

Use of Acthar in Rheumatoid Arthritis Related Flares

Last checked: Nov 20, 2026Latest source record: Aug 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

40

Actual

Start

Jul 20, 2017

Primary completion

May 6, 2025

Study completion May 20, 2025

Sponsor

Lead sponsor
Veena Ranganath, MD, MSAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Mallinckrodt
First posted
Sep 4, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Diagnostic
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Rheumatoid Arthritis (RA) study. The purpose of this research study is to determine in RA flare, whether musculoskeletal ultrasound (MSUS) inflammatory scores and/or disease activity scores improve with Acthar treatment.

Conditions

  • Rheumatoid Arthritis (RA)

Interventions

  • ActharDrug

    Injections will be self administered

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. DAS28Time frame: Baseline to 4 Weeks
  2. Power Doppler Ultrasound ScoreTime frame: Baseline to 4 Weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • UCLA David Geffen School of Medicine, Division of Rheumatology

    Los Angeles, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.